26 November 2021

Gurutz Linazasoro has been awarded a 2021 Korta Award

The CEO of VIVEbiotech, Gurutz Linazasoro, has received one of the four 2021 Korta Awards delivered this past Wednesday by the Lehendakari Iñigo Urkullu.

Read more

28 October 2021

Successful participation of VIVEbiotech in five international meetings in the last half of the year

VIVEbiotech has participated very successfully in five international meetings since the summer.

Read more

22 October 2021

Juan Carlos Ramírez, CSO/CTO of VIVEbiotech, forever in science and in our hearts

VIVEbiotech colleagues have lived a very painful week due to the death of our colleague and friend Juan Carlos Ramírez.

Read more

28 July 2021

Video-report about VIVEbiotech in El Exportador

The digital magazine ‘El Exportador’, edited by ICEX Spain Exports and Investments -the Spanish Institute for Foreign Trade-, has published a video-report on VIVEbiotech as...

Read more

7 July 2021

VIVEbiotech obtains the seal of a Company Committed to Youth Employment

This seal is a recognition to VIVEbiotech for its commitment to the Comprehensive Qualification and Employment Program.

Read more

23 June 2021

New publication in Cell and Gene Therapy Insights

VIVEbiotech publishes an article entitled “Lentiviral vectors: key challenges and new developments” in the journal Cell and Gene Therapy Insights.

Read more

4 June 2021

VIVEbiotech launches lentiviral vector manufacturing plant for cell and gene therapy sector

VIVEbiotech’s production capacity will increase by 400%, with an increase in average batch size per year from 20 in 2020 to 80 in 2022.

Read more

27 April 2021

Report about VIVEbiotech in El Confidencial

On the occasion of being a finalist for the 2020 Pyme Award, Banco Santander has made known the great work we do at VIVEbiotech manufacturing lentiviral...

Read more

18 March 2021

VIVEbiotech participates in the “V. Professional Training Forum in biotech companies”

FP/Parke is an initiative that aims to arouse the interest of the youngest in technological professions with the collaboration of leading companies in the...

Read more

26 February 2021

DEFACTO selects VIVEbiotech to include it in its project

The marketing and communication consultancy DEFACTO has selected VIVEbiotech as a chameleon company that has known how to adapt to the COVID-19 crisis.

Read more